Immuron
IMRN
5 hedge funds and large institutions have $728K invested in Immuron in 2021 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
70% more capital invested
Capital invested by funds: $428K → $728K (+$300K)
0% more funds holding
Funds holding: 5 → 5 (0)
0.52% less ownership
Funds ownership: 3.75% → 3.23% (-0.52%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$6.13K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$79.5K |
| 2 |
Renaissance Technologies
New York
|
-$52.2K |
IMRN Hedge Fund Activity: Q3 2021 in Review
5 of the 5,729 institutional investors tracked by Wall St. Rank reported a position in Immuron (IMRN) for Q3 2021, worth a combined $728K — up 70% from $428K a quarter earlier.
Fund positioning in IMRN was balanced in Q3 2021: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was UBS Group, adding an estimated $6.13K. The largest seller was Morgan Stanley, cutting an estimated $79.5K.
- 5 institutional investors held Immuron (IMRN) as of Q3 2021, unchanged from Q2 2021.
- Funds reported $728K of Immuron stock for Q3 2021, up 70% quarter-over-quarter.
- 0 funds opened new Immuron positions in Q3 2021 and 0 closed out.
- The largest Immuron buyer in Q3 2021 was UBS Group, an estimated $6.13K added.
- The largest Immuron seller in Q3 2021 was Morgan Stanley, an estimated $79.5K sold.
Based on aggregated 13F filings for Q3 2021.